Description
RADIOPHARMECUTICALS OPTION YEAR 1
Base award description: RADIOPHARMECUTICALS
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-06-10+$148,209= $148,209
- Mod P000012021-04-28+$11,320= $159,529
- Mod P000022021-04-28+$158,824= $318,352
- Mod P000032022-02-04-$110,309= $208,043
- Mod P000042023-05-21-$92,875= $115,168
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-06-10 | +$148,209 | $148,209 | RADIOPHARMECUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-04-28 | +$11,320 | $159,529 | RADIOPHARMECUTICALS |
| Mod P00002· EXERCISE AN OPTION | 2021-04-28 | +$158,824 | $318,352 | RADIOPHARMECUTICALS OPTION YEAR 1 |
| Mod P00003· FUNDING ONLY ACTION | 2022-02-04 | −$110,309 | $208,043 | RADIOPHARMECUTICALS OPTION YEAR 1 |
| Mod P00004· FUNDING ONLY ACTION | 2023-05-21 | −$92,875 | $115,168 | RADIOPHARMECUTICALS OPTION YEAR 1 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EQ4VSLH8RC33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0411 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $231,773 | FY2026 |
| 36C24126N0274 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $771,411 | FY2026 |
| 36C25226N0210 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $164,999 | FY2026 |
| 36C26126N0065 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $153,991 | FY2026 |
| 36C24825N0208 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $224,563 | FY2025 |
| 36C24125N0495 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $656,883 | FY2025 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26120P1092_3600_-NONE-_-NONE- · retrieved 2026-09-26.